[Iproplatin--advantages and disadvantages of a new platinum cytostatic agent].
Hejl
J
J
Hejlová
N
N
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; C023359:iproplatin
Iproplatina--výhody a nevýhody nového platinového cytostatika.